ArticleModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2022
MIXTURE of human expertise and deep learning-developing an explainable model for predicting pathological diagnosis and survival in patients with interstitial lung disease.
Article in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 47 citations in OpenAlex.
- Toward precision imaging in interstitial lung disease: advances in quantitative imaging and artificial intelligence.Current opinion in pulmonary medicine · 2026Review
- A scoping review of human-AI collaboration patterns and task divisions in healthcare applications.NPJ digital medicine · 2026Article
- [Artificial intelligence-assisted diagnostics in the pathology of internal and oncological diseases].Innere Medizin (Heidelberg, Germany) · 2026Review
- Artificial intelligence chatbots in endodontic education-Concepts and potential applications.International endodontic journal · 2026Review
- Artificial intelligence-enabled histological analysis in pre-clinical respiratory disease models: a scoping review.European respiratory review : an official journal of the European Respiratory Society · 2026Article
- Artificial intelligence in idiopathic pulmonary fibrosis: advances, challenges and future directions.The European respiratory journal · 2026Review
- AI-Powered Histology for Molecular Profiling in Brain Tumors: Toward Smart Diagnostics from Tissue.Cancers · 2025Review
- Enhancing Interstitial Lung Disease Diagnoses Through Multimodal AI Integration of Histopathological and CT Image Data.Respirology (Carlton, Vic.) · 2025Article
- The Use of Artificial Intelligence in Endodontics.Journal of dental research · 2024Review
- Machine learning classifier is associated with mortality in interstitial lung disease: a retrospective validation study leveraging registry data.BMC pulmonary medicine · 2024Article
- Artificial intelligence in digital pathology: a systematic review and meta-analysis of diagnostic test accuracy.NPJ digital medicine · 2024Review
- Extracting interpretable features for pathologists using weakly supervised learning to predict p16 expression in oropharyngeal cancer.Scientific reports · 2024Article
- A Novel Automatic Algorithm to Support Lung Ultrasound Non-Expert Physicians in Interstitial Pneumonia Evaluation: A Single-Center Study.Diagnostics (Basel, Switzerland) · 2024Article
- Diagnosis of interstitial lung diseases: from Averill A. Liebow to artificial intelligence.Journal of pathology and translational medicine · 2024Review
- Application of digital pathology and machine learning in the liver, kidney and lung diseases.Journal of pathology informatics · 2023Review
- Automated Classification of Idiopathic Pulmonary Fibrosis in Pathological Images Using Convolutional Neural Network and Generative Adversarial Networks.Diagnostics (Basel, Switzerland) · 2022Article
- A collaborative workflow between pathologists and deep learning for the evaluation of tumour cellularity in lung adenocarcinoma.Histopathology · 2022Article
- Pulmonary Fibrosis as a Result of Acute Lung Inflammation: Molecular Mechanisms, Relevant In Vivo Models, Prognostic and Therapeutic Approaches.International journal of molecular sciences · 2022Review
- Identification of technology frontiers of artificial intelligence-assisted pathology based on patent citation network.PloS one · 2022Review
- Self-supervised learning mechanism for identification of eyelid malignant melanoma in pathologic slides with limited annotation.Frontiers in medicine · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 6 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Interstitial pneumonia is a heterogeneous disease with a progressive course and poor prognosis, at times even worse than those in the main cancer types. Histopathological examination is crucial for its diagnosis and estimation of prognosis. However, the evaluation strongly depends on the experience of pathologists, and the reproducibility of diagnosis is low. Herein, we propose MIXTURE (huMan-In-the-loop eXplainable artificial intelligence Through the Use of REcurrent training), an original method to develop deep learning models for extracting pathologically significant findings based on an expert pathologist's perspective with a small annotation effort. The procedure of MIXTURE consists of three steps as follows. First, we created feature extractors for tiles from whole slide images using self-supervised learning. The similar looking tiles were clustered based on the output features and then pathologists integrated the pathologically synonymous clusters. Using the integrated clusters as labeled data, deep learning models to classify the tiles into pathological findings were created by transfer-learning the feature extractors. We developed three models for different magnifications. Using these extracted findings, our model was able to predict the diagnosis of usual interstitial pneumonia, a finding suggestive of progressive disease, with high accuracy (AUC 0.90 in validation set and AUC 0.86 in test set). This high accuracy could not be achieved without the integration of findings by pathologists. The patients predicted as UIP had poorer prognosis (5-year overall survival [OS]: 55.4%) than those predicted as non-UIP (OS: 95.2%). The Cox proportional hazards model for each microscopic finding and prognosis pointed out dense fibrosis, fibroblastic foci, elastosis, and lymphocyte aggregation as independent risk factors. We suggest that MIXTURE may serve as a model approach to different diseases evaluated by medical imaging, including pathology and radiology, and be the prototype for explainable artificial intelligence that can collaborate with humans.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.